Product Images Aripiprazole

This text presents information on the effect of various drugs on aripiprazole, a medication used to treat mental disorders. The text mentions the role of certain enzymes, such as CYP3A4 and CYP2DG, in the metabolism of aripiprazole, and how inhibitors or inducers of these enzymes may affect the drug's performance. The text also lists several other drugs, such as carbamazepine, famotidine, and valproate, that may interact with aripiprazole. Finally, the text displays a graph showing the fold change and confidence interval of aripiprazole compared to a reference value in the presence of interacting drugs.*

This text provides a chart displaying the effect of various drugs on the levels of aripiprazole in the body. It shows whether they inhibit or induce the enzymes responsible for breaking down aripiprazole and includes fold changes and confidence intervals for dehydro-aripiprazole.*

This is a list of drugs and their effects when interacting with Aripiprazole, with a focus on how Aripiprazole affects their pharmacokinetics. The list includes Warfarin, Omeprazole, Lamotrigine, Valproate, Lorazepam, Venlafaxine, and Escitalopram. It also includes fold change and 90% confidence intervals for these drugs, but the information is incomplete and difficult to interpret without further context.*

This text appears to be presenting various categories and comparisons related to special populations, such as individuals with poor vs. extensive metabolism, females vs. males, different age ranges, and varying degrees of hepatic and renal impairment. It also includes some measurements related to pharmacokinetics, specifically the AUC for a drug called Avipiprazole and its fold change, as well as a graph showing relative changes in GI.*

The text seems to be presenting results of a study involving a drug called Aripiprazole. The study looked at the effect of variables like gender, age, hepatic and renal impairment on the maximum concentration (Cmax) and the area under the curve (AUC) of the drug. The text also provides data on the Dehydro-Aripiprazole Fold Change and its 90% confidence interval. Overall, the description suggests that the text is related to pharmacological research.*

This is a clinical trial data that compares Aripiprazole (a drug used to treat various mental/mood problems such as bipolar disorder, schizophrenia, and irritability associated with autistic disorder) vs placebo. The study measured the proportion of subjects who experienced a relapse over a period of 182 days using the number of subjects at risk. The data shows that Aripiprazole was effective in reducing the risk of relapse compared to placebo.*

Not available.*

This is a medicine label for tablets containing Roa G 2 mg, which is to be taken with accompanying Aripiprazole. Each bottle comes with 30 tablets and should be stored between 20°C and 25°C, with the container tightly closed and kept away from children. The manufacturer is Unichem Laboratories, based in Ghaziabad, India, and it's for distribution by Unichem Pharmaceuticals, based in East Brunswick, NJ, USA. The label also includes the NDC number 29300-175-13 and a lot number 13003663, with a manufacturing date of March 2020.*

This is a medication package containing tablets of Avipiprazole, USP 5mg strength, manufactured by Unichem Laboratories LTD. The tablets are prescribed as an adjunct to Aripiprazole. It is recommended to keep the container tightly closed and store it between 20°C to 25°C. The package insert warns to keep this drug out of reach of children and includes 30 tablets. It also advises the pharmacist to dispense the accompanying Medication Guide to each patient. The NDC number of the medication is 29300-176-13.*

This is a description of a medication with the NDC number 29300-177-13. It is a package of 30 tablets containing 10mg of Apiprazole. The tablets are meant to be stored at a temperature of 68°F to 77°F (20°C to 25°C) and kept out of reach of children. The container should be tightly closed. The medication is manufactured by Unichem Laboratories Ltd., located in Ghaziabad, India, and is distributed by Unichem Pharmaceuticals in the US.*

This is a medication called EachTablet Contal containing Apiprazole 15 mg used for treatment as described in the accompanying package insert. It should be stored within the temperature range of 20° to 25°C and kept out of reach of children. The medication guide should be given to each patient by the pharmacist. The medication container should remain tightly closed. The manufacturer is Unichem Laboratories Ltd. in Ghaziabad, India, and the medication is distributed in the USA by Unichem Pharmaceuticals. The package contains 30 tablets.*

This is a package insert for Aripiprazole tablets containing 20mg of the medication. The tablets should be stored at controlled room temperature and kept out of reach of children. Each tablet must be taken according to the accompanying medication guide. Manufactured by Unichem Laboratories LTD based in India and distributed in the USA by Unichem Pharmaceuticals.*

This is the description for the drug Apiprazole, NDC code 29300-180-13. Each tablet contains 30mg of Apiprazole, USP. The accompanying Aripiprazole packaging insert should be consulted for usual dosage. The tablets should be stored at controlled room temperature, between 20°C to 25°C. The container should be tightly closed and all drugs should be kept out of reach of children. The drug is manufactured by Unichem Laboratories Ltd. in India and distributed by Unichem Pharmaceuticals (USA), Inc. The package only contains 30 tablets.*